PMC:7594251 / 184-365
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T7999 | 174-179 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 51-61 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T2 | 167-173 | Disease | denotes | Cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T32708 | 6-7 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T17685 | 22-27 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T97528 | 72-73 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T35994 | 174-179 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T3 | 150-154 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 7 | 22-27 | Species | denotes | human | Tax:9606 |
| 9 | 51-61 | Disease | denotes | infections | MESH:D007239 |
| 10 | 167-173 | Disease | denotes | Cancer | MESH:D009369 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T77349 | 150-165 | http://purl.obolibrary.org/obo/GO_0042493 | denotes | drug resistance |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 150-165 | Phenotype | denotes | drug resistance | http://purl.obolibrary.org/obo/HP_0020174 |
| T2 | 167-173 | Phenotype | denotes | Cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 41-166 | Sentence | denotes | Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. |